In vitro gametogenesis
Turning ordinary body cells into functional eggs or sperm in culture, giving an essentially unlimited supply of gametes from one donor.
State of the art
Conception reported the first stem-cell-derived human early-egg cells within lab-grown follicle structures (June 2026); the alternative nuclear-transfer route produced 82 human oocytes of which under 9 percent reached blastocyst (2025); mouse IVG produced healthy, fertile pups (Hayashi, 2016).
- Human oocyte maturation needs months of follicle growth that culture cannot yet sustain
- Meiotic recombination and chromosome segregation are error-prone outside the ovary, giving aneuploidy
- Imprinting marks are set during germ-cell development and are mis-set in vitro, with no safety assay short of a live birth
Who’s working on it
- Conception Biosciences ↗Startup
Reported the first stem-cell-derived human primary oocytes inside entirely iPSC-derived follicle structures, from a blood draw (June 2026)
- Katsuhiko HayashiResearcherOsaka University
Produced healthy fertile mouse pups from iPSC-derived eggs (2016), the only complete mammalian IVG demonstration, and collaborates with Conception
- Mitinori Saitou ↗ResearcherASHBi, Kyoto University
Generated human oogonia from iPSCs (Science, 2018) and reconstituted human germline epigenetic reprogramming in vitro (Nature, 2024), defining the steps the field has to reproduce
- Gameto ↗Startup
Its iPSC-derived ovarian support cell product Fertilo produced the first live birth from stem-cell-assisted egg maturation (December 2024) and is in Phase 3 after a $44M Series C in August 2025
- OvelleStartup
Boston company founded in 2024 working on human in vitro oogenesis via meiotic oogonia in ovarian organoids; disclosed about $7M of a $9.2M offering in 2026
- Shoukhrat MitalipovResearcherOregon Health & Science University
Pursues the nuclear-transfer alternative to stem-cell IVG; his team produced 82 human oocytes of which under 9 percent reached blastocyst (2025)
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Benchmarked human follicle culture systems with stage-by-stage comparison against natural ovary single-cell atlases | $$ $10M – $100M |
| research | Imprinting and aneuploidy assay development so candidate gametes can be screened without a pregnancy | $$ $10M – $100M |
Depends on
A root node: no prerequisites modeled.